FDA Communication on Use of Jet Injectors with Influenza Vaccines
MedSun: Newsletter #66, November 2011

FDA Center for Biologics Evaluation and Research

The FDA is clarifying its October 21, 2011 communication to inform the public that inactivated influenza vaccines labeled for IM injection are intended for administration using a sterile needle and syringe. FDA has recently received questions regarding the use of jet injector devices to administer inactivated influenza vaccines. There is one inactivated influenza vaccine labeled for ID administration, this vaccine is supplied in its own pre-filled syringe. The live attenuated influenza vaccine is given through the nose as a spray; the sprayer is not a jet injector. Currently, there is only one vaccine, Measles, Mumps and Rubella (MMR), that is approved and specifically labeled for administration by jet injector. At this time, there are no inactivated influenza vaccines that are approved and specifically labeled by the FDA for administration by jet injector.

Additional Information:

FDA Communication on Use of Jet Injectors with Influenza Vaccines. FDA Center for Biologics Evaluation and Research. October 26, 2011.
http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm276773.htm


MedSun Newsletters are available at www.fda.gov/cdrh/medsun